Related Experiment Video
Updated: May 19, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Drug compliance in patients with systemic scleroderma
Lucie Hromadkova1, Tomas Soukup, Eva Cermakova
1Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic. lucie.hromadkova@faf.cuni.cz
Clinical Rheumatology
|August 10, 2012
Summary
This study found that only 42% of systemic scleroderma patients have adequate drug compliance. Common risk factors for noncompliance were not identified, suggesting individual patient factors are key.
Area of Science:
- Rheumatology
- Pharmacology
- Patient Adherence Studies
Background:
- Drug compliance is vital for chronic disease treatment effectiveness.
- Compliance has not been previously assessed in systemic scleroderma patients.
Purpose of the Study:
- To determine the drug compliance rate in systemic scleroderma patients.
- To identify potential risk factors associated with noncompliance in this population.
Main Methods:
- A cross-sectional observational study design was employed.
- Data collected via structured interviews and medical records from 41 systemic scleroderma patients.
- The Compliance Questionnaire Rheumatology (CQR) assessed patient compliance.
Main Results:
- The mean CQR score was 75%, indicating suboptimal compliance.
- Only 42% of patients met the satisfactory compliance threshold (≥80%).
- No significant relationships were found between compliance and demographic or clinical characteristics.
Conclusions:
- This is the first study evaluating drug compliance in systemic scleroderma.
- A significant proportion of patients exhibit noncompliance.
- Common risk factors for noncompliance were not identified, highlighting the role of individual patient factors.
Related Concept Videos
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...